跳至主要内容
临床试验/CTRI/2021/03/032042
CTRI/2021/03/032042尚未招募不适用

Clinical and scientific evaluation of Gudabhransa (Prolaps of Rectum) and its management

DrNagesh Kumar Yadav1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年12月4日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Wexner Incontinence score

研究概览

简要总结

This study is a randomized trial done in India for Clinical and scientific evaluation of Gudabhransa (Prolapse of Rectum) and its management through Ayurvedic oral drug therapy, Basti therapy and surgical procedure, modified thiersch EACKS method. The primary outcome measures the Wexner incontinence score at 3 months.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
10.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Partial prolapse of rectum Mucosal Prolapse patients not willing for major surgery.

排除标准

  • Prolapse haemorrhoids Carcinoma of rectum Complete rectal prolapse Cystocoel Rectocoel Colitis Uncontrolled diabetic mellitus Immuno-compromised patients Sentinel Tag Haemorrhoid HIV/HBsAg positive subjects Patient with any systemic infection.

结局指标

主要结局

Wexner Incontinence score

时间窗: 3 months

次要结局

  • ANAL TONE BY PER RECTAL DIGITAL EXAMINATION(1 month)
  • ANAL TONE BY anal manometry(1 month)

研究者

发起方
DrNagesh Kumar Yadav
申办方类型
Other [Phd Student]

研究点 (1)

Loading locations...

相似试验